ReviewHaematologica2025

New approaches to standard of care in early-phase myeloproliferative neoplasms: can interferon-α alter the natural history of the disease?

Florence Pasquier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.